NL193820C - Vaste farmaceutische doseringsvorm voor orale toediening van Ibuprofen. - Google Patents

Vaste farmaceutische doseringsvorm voor orale toediening van Ibuprofen. Download PDF

Info

Publication number
NL193820C
NL193820C NL9401005A NL9401005A NL193820C NL 193820 C NL193820 C NL 193820C NL 9401005 A NL9401005 A NL 9401005A NL 9401005 A NL9401005 A NL 9401005A NL 193820 C NL193820 C NL 193820C
Authority
NL
Netherlands
Prior art keywords
dosage form
lbuprofen
arginine
administration
mixture
Prior art date
Application number
NL9401005A
Other languages
English (en)
Dutch (nl)
Other versions
NL193820B (nl
NL9401005A (nl
Inventor
Daniele Bonadeo
Federico Stroppolo
Gian Franco Fornasini
Annibale Gazziniga
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Publication of NL9401005A publication Critical patent/NL9401005A/nl
Publication of NL193820B publication Critical patent/NL193820B/xx
Application granted granted Critical
Publication of NL193820C publication Critical patent/NL193820C/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
NL9401005A 1993-06-21 1994-06-20 Vaste farmaceutische doseringsvorm voor orale toediening van Ibuprofen. NL193820C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI931325 1993-06-21
IT93MI001325A IT1264856B1 (it) 1993-06-21 1993-06-21 Composizione farmaceutica ad attivita' analgesica

Publications (3)

Publication Number Publication Date
NL9401005A NL9401005A (nl) 1995-01-16
NL193820B NL193820B (nl) 2000-08-01
NL193820C true NL193820C (nl) 2000-12-04

Family

ID=11366436

Family Applications (1)

Application Number Title Priority Date Filing Date
NL9401005A NL193820C (nl) 1993-06-21 1994-06-20 Vaste farmaceutische doseringsvorm voor orale toediening van Ibuprofen.

Country Status (15)

Country Link
US (2) US5500226A (ja)
JP (1) JPH07101855A (ja)
BE (1) BE1007194A3 (ja)
CA (1) CA2125643C (ja)
CH (1) CH687850A5 (ja)
DE (1) DE4420856A1 (ja)
DK (1) DK174687B1 (ja)
ES (1) ES2099021B1 (ja)
FR (1) FR2706892B1 (ja)
GB (1) GB2279250B (ja)
HU (1) HU211669A9 (ja)
IT (1) IT1264856B1 (ja)
NL (1) NL193820C (ja)
NO (1) NO310443B1 (ja)
SE (1) SE9402157L (ja)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1264856B1 (it) * 1993-06-21 1996-10-17 Zambon Spa Composizione farmaceutica ad attivita' analgesica
US5654334A (en) * 1995-06-23 1997-08-05 Oklahoma Medical Research Foundation Analgesic use of N-L-α-aspartyl-L-phenylalanine 1-methyl ester
US5707967A (en) * 1995-10-27 1998-01-13 Vanmoor; Arthur Pain relief compositions
CA2266098A1 (en) * 1996-09-26 1998-04-02 Oklahoma Medical Research Foundation Use of n-l-alpha-aspartyl-l-phenylalanine 1-methyl ester and its derivatives in disease regression
WO1999051252A1 (en) 1998-04-03 1999-10-14 The Daily Wellness Company Compositions comprising l-arginine, ginseng and gingko biloba for enhancing blood circulation
IT1301966B1 (it) 1998-07-30 2000-07-20 Zambon Spa Composizioni farmaceutiche ad attivita' analgesica
KR100523242B1 (ko) * 2000-05-18 2005-10-24 한미약품 주식회사 이부프로펜을 함유하는 정제 조성물
US20020192161A1 (en) * 2001-04-10 2002-12-19 Fahkreddin Jamali Animal model for evaluating analgesics
US6727286B2 (en) 2001-11-02 2004-04-27 Cumberland Pharmaceuticals Inc. Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid
US20050137262A1 (en) * 2003-12-22 2005-06-23 Hu Patrick C. Highly concentrated pourable aqueous solutions of potassium ibuprofen, their preparation and their uses
KR100678837B1 (ko) * 2005-01-03 2007-02-05 한미약품 주식회사 활성 성분으로 덱시부프로펜을 함유하는 시럽제 조성물 및그의 제조 방법
KR100730393B1 (ko) 2005-06-10 2007-06-20 한국콜마 주식회사 이부프로펜 및 아르기닌을 함유하는 약학 조성물의제조방법
ES2303468B1 (es) * 2007-01-22 2009-06-08 Masterfarm, S.L "una composicion farmaceutica pulverulenta que comprende ibuprofeno".
MX2010004974A (es) * 2010-05-04 2011-11-23 Senosiain S A De C V Lab Combinacion de un aine y un aminoacido.
WO2015016256A1 (ja) * 2013-07-30 2015-02-05 ライオン株式会社 錠剤

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1209667B (it) * 1985-11-12 1989-08-30 Zambon Spa Composizione effeverscente adattivita' analgesica.
IT1197038B (it) * 1986-08-01 1988-11-25 Zambon Spa Composizione farmaceutica ad attivita' analgesica
ATE50493T1 (de) * 1986-11-14 1990-03-15 Puetter Medice Chem Pharm Ibuprofen enthaltendes arzneimittel.
US4851444A (en) * 1987-07-10 1989-07-25 Analgesic Associates Onset-hastened/enhanced analgesia
US5262179A (en) * 1989-09-13 1993-11-16 Nicholas Kiwi Pty Ltd. Non-effervescent ibuprofen compositions
ATE128452T1 (de) * 1989-10-17 1995-10-15 Merck & Co Inc S(+)-ibuprofen-l-aminosäure und s(+)-ibuprofen-d- aminosäure als analgetika mit grösserem pharmakologischem potential.
IT1264856B1 (it) * 1993-06-21 1996-10-17 Zambon Spa Composizione farmaceutica ad attivita' analgesica

Also Published As

Publication number Publication date
GB2279250A (en) 1995-01-04
NL193820B (nl) 2000-08-01
DK72594A (da) 1994-12-22
GB2279250B (en) 1998-02-25
ES2099021B1 (es) 1998-01-16
DE4420856A1 (de) 1994-12-22
NO942343D0 (ja) 1994-06-20
FR2706892A1 (ja) 1994-12-30
BE1007194A3 (fr) 1995-04-18
ITMI931325A1 (it) 1994-12-21
CA2125643A1 (en) 1994-12-22
NO942343L (no) 1994-12-22
NO310443B1 (no) 2001-07-09
NL9401005A (nl) 1995-01-16
CA2125643C (en) 2007-09-04
CH687850A5 (it) 1997-03-14
ES2099021A1 (es) 1997-05-01
SE9402157L (sv) 1994-12-22
US5500226A (en) 1996-03-19
US5645857A (en) 1997-07-08
JPH07101855A (ja) 1995-04-18
DK174687B1 (da) 2003-09-15
SE9402157D0 (sv) 1994-06-20
FR2706892B1 (ja) 1995-10-20
HU211669A9 (en) 1995-12-28
IT1264856B1 (it) 1996-10-17
ITMI931325A0 (it) 1993-06-21
GB9410898D0 (en) 1994-07-20

Similar Documents

Publication Publication Date Title
NL193820C (nl) Vaste farmaceutische doseringsvorm voor orale toediening van Ibuprofen.
NL193307C (nl) Bruispreparaat met analgetische werkzaamheid.
NL194031C (nl) Farmaceutische samenstelling met een analgetische werking en daaruit met geschikte excipiÙntia gevormd granulaat.
DK2531200T3 (en) COSTALLIZATION PROCEDURE AND BIOTA ACCESSIBILITY
CA2536175C (en) Pharmaceutical compositions and method of using levodopa and carbidopa
RU2429830C2 (ru) Трансмукозальное введение 2,3-диметокси-5-метил-6-(10-гидроксидецил)-1,4-бензохинона
WO2012117257A1 (en) Diethylstilbestrol dosage form and use for the treatment of prostate or breast cancer
WO2005099678A1 (en) Pharmaceutical compositions and method of using levodopa and carbidopa
JP3784843B2 (ja) 鎮痛作用を有する薬剤組成物
EP1159960B1 (en) Pharmaceutical compositions based on diclofenac
RU2761828C2 (ru) Фармацевтическая композиция, содержащая бензокаин с усиленной стабильностью
US12042491B1 (en) Pharmaceutical formulations of quinolines
Chiang et al. Formulation development of an oral dosage form for an HIV protease inhibitor, AG1284
KR20100057423A (ko) 덱시부프로펜의 염 및 이를 함유하는 경구용 약학 조성물의제조방법
KR100667366B1 (ko) 용해도가 개선된 글리메피리드 복합체 조성물 및 그의 제조방법
WO2024141623A1 (en) Liquid pharmaceutical formulations of quinolines
Dąbrowska-Maś et al. New approaches to the synthesis of diclofenac choline
TR2024007612T2 (tr) Amorf tolvaptan i̇çeren formülasyonlar i̇çi̇n i̇yi̇leşti̇ri̇lmi̇ş üreti̇m yöntemi̇
KR19990084221A (ko) Hiv 프로테아제 억제제를 포함하는 약학적 조성물 및 이의경구투여용 제형

Legal Events

Date Code Title Description
BB A search report has been drawn up
BC A request for examination has been filed
V4 Discontinued because of reaching the maximum lifetime of a patent

Effective date: 20140620